EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment improves left ventricular hypertrophy and quality of life in stage 1 isolated systolic hypertension



Treatment improves left ventricular hypertrophy and quality of life in stage 1 isolated systolic hypertension



Journal of Hypertension 18(Suppl 4): S157




(PDF 0-2 workdays service: $29.90)

Accession: 035980264

Download citation: RISBibTeXText



Related references

Feoldipine improves left ventricular hypertrophy and quality of life in Stage 1 isolated systolic hypertension. American Journal of Hypertension 13(4 Part 2): 61A, April, 2000

Left ventricular mass changes in patients with isolated systolic or combined hypertension and echocardiographic left ventricular hypertrophy The LIFE study. American Journal of Hypertension 16(5 Part 2): 126A-127A, 2003

Effect of antihypertensive therapy on left ventricular geometry and function in patients with isolated systolic or combined hypertension and electrocardiographic left ventricular hypertrophy The LIFE study. Circulation 100(18 SUPPL ): I 808, Nov 2, 1999

Left ventricular hypertrophy is a frequent finding in older patients with stage I isolated systolic hypertension. Circulation 96(8 SUPPL ): I600, 10/21/97, 1997

Similar improvement in left ventricular structure and function, despite differences in blood pressure control, with long-term antihypertensive therapy in patients with isolated systolic or combined hypertension and left ventricular hypertrophy The LIFE study. American Journal of Hypertension 16(5 Part 2): 178A, 2003

Effect of antihypertensive treatment on the prevalence of ventricular arrhythmias among patients with isolated systolic hypertension without left ventricular hypertrophy. Current Therapeutic Research 63(1): 27-32, January, 2002

Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension. Journal of Hypertension 17(8): 1203-1207, 1999

Compliance of peripheral conduit arteries is increased in isolated systolic hypertension accompanied by left ventricular hypertrophy, a life-substudy. American Journal of Hypertension 14(4 Part 2): 123A, April, 2001

Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study). American Journal of Cardiology 100(5): 855-859, 2007

The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study. Journal of Clinical Hypertension 7(3): 152-158, 2005

Is isolated systolic hypertension in the elderly more associated with left ventricular hypertrophy and significant carotid artery stenosis than mixed hypertension and isolated diastolic hypertension?. Journal of Human Hypertension 9(10): 809-813, 1995

Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (the LIFE study). American Journal of Cardiology 87(1): 54-60, 2001

Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint. American Journal of Cardiology 87(1): 54-60, 2001

Isolated systolic hypertension results, in part, from left ventricular hypertrophy. FASEB Journal 13(4 PART 1): A118, March 12, 1999

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 288(12): 1491-1498, 2002